Power Law company profile

Sana Biotechnology

Biotech & Life Sciences · Seattle, United States · Founded 2018 · IPO 2021 Unicorn

← All companies

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation

$821M

Market cap · Apr/2026

Investors

12 investors on Sana Biotechnology's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Seed 4 investors entered at this stage

F-Prime

Bradley Horowitz

ARCH Venture Partners

Flagship Pioneering

Series A 7 investors entered at this stage

Alaska Permanent Fund

Baillie Gifford

Bezos Expeditions

Omega Funds

Altitude Life Science Ventures

PSP Investments

CPP Investments

Series B+ 1 investor entered at this stage

Harvard University

Global footprint

Where Sana Biotechnology has talent and traffic

AI talent share

0.4% of workforce is AI talent
(1 of 261 staff)

Core AI00%

Other AI10.38%

Non-AI workforce26099.62%

Web traffic by country

28K monthly visits
across markets

🇺🇸 United States62.5%

🇨🇦 Canada7.9%

🇬🇧 United Kingdom6.1%

🇯🇵 Japan5.7%

🇮🇳 India5.4%

Top 5 markets shown

Patent intelligence

$10M patent portfolio · 60 active families

Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.

Estimated portfolio value

$10M

1.3% of market cap · 196.5× smaller than top peer Ablynx ($2B)

60 active patent families

Where Sana Biotechnology innovates Molecular biologyViral vectorCell biologyCD47Bioinformatics

Below peer median on Market

Quality vs same-sector peers

Sana Biotechnology on the five Patsnap quality dimensions

Sana Biotechnology in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.

Compare against

Patent quality scores (0–100)

Source: Dealroom Patent Intelligence · Patsnap

Tech-focus vs peers

Where Sana Biotechnology concentrates inside the peer cluster

Axes are the most-shared Patsnap topics across Sana Biotechnology and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).

Compare against

Top-topic prominence (rank inverted, 0–100)

Source: Dealroom Patent Intelligence · Patsnap top-10 topics per company

This is teaser data. The full per-sub-category breakdown, individual patent records, and quality-score history are on the Dealroom platform — request a demo to access.

See Sana Biotechnology on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Open in Dealroom Book a demo